# A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection

> **NCT00000919** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 900 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Indinavir sulfate
- **DRUG:** Lamivudine/Zidovudine
- **DRUG:** Ritonavir
- **DRUG:** Hydroxyurea
- **DRUG:** Abacavir sulfate
- **DRUG:** Amprenavir
- **DRUG:** Nelfinavir mesylate
- **DRUG:** Efavirenz
- **DRUG:** Lamivudine
- **DRUG:** Stavudine
- **DRUG:** Zidovudine
- **DRUG:** Didanosine

## Key facts

- **NCT ID:** NCT00000919
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2002-11
- **Target enrollment:** 900 (—)
- **Last updated:** 2012-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000919, "A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00000919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*